Chordia Therapeutics Inc.

TSE:190A Stock Report

Market Cap: JP¥18.7b

Chordia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 190A?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders900,0001.33%
Institutions8,881,00013.1%
Public Companies10,760,50015.9%
General Public19,236,40028.4%
VC/PE Firms27,900,90041.2%

Dilution of Shares: 190A only recently listed within the past 12 months


Top Shareholders

Top 13 shareholders own 75.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
Takeda Pharmaceutical Company Limited
10,760,500JP¥3.0b0%no data
11%
Kyoto University Innovation Capital Co., Ltd.
7,408,000JP¥2.0b-6.87%no data
10.7%
Shinsei Capital Partners
7,252,100JP¥2.0b0%75.08%
7.47%
Nomura SPARX Investment Inc.
5,052,800JP¥1.4b0%no data
6.22%
SBI Investment Co., Ltd.
4,210,800JP¥1.2b0%5.67%
5.88%
Mitsubishi UFJ Capital Co., Ltd.
3,977,200JP¥1.1b0%5.58%
4.52%
JAFCO Group Co., Ltd.
3,060,400JP¥844.7m-43.9%4.35%
4.5%
SMBC Venture Capital Co., Ltd.
3,046,700JP¥840.9m-23.3%38.12%
3.93%
Nippon Venture Capital Co., Ltd.
2,660,600JP¥734.3m0%13.73%
3.68%
UTokyo Innovation Platform Co., Ltd.
2,492,400JP¥687.9m-26%93.01%
1.33%
Hiroshi Miyake
900,000JP¥248.4m0%no data
0.39%
SBI Holdings Inc., Asset Management Arm
260,900JP¥72.0m0%0.02%
0.15%
Simplex Asset Management Co., Ltd.
101,400JP¥28.0m0.4%0.02%